MedTrace Logo

Prehospital Prediction of Large Anterior Vessel Occlusion

NCT04442659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-06-22

No results posted yet for this study

Summary

For the clinical benefit of intravenous thrombolysis "IVT" or intra-arterial thrombectomy "IAT" time is the most crucial factor. Reducing the time between stroke onset en treatment is therefore a major goal. Since IAT is only suitable for stroke due to large anterior vessel occlusion "LAVO" which is only performed in specialized comprehensive stroke centers "CSC", triage of LAVO-patients in the prehospital phase (i.e. in the ambulance) in order to directly allocate them to such a specialized CSC will save vital time (time=brain!). Several LAVO-prediction scales for clinical triage have been developed but most were tested in- hospital by experienced neurologists. Consequently, there is a great need for validation of these scales in the prehospital setting by Emergency Medical Services "EMS" personnel.

Objective: to recalibrate, validate performance and assess feasibility of several existing LAVO-prediction scales in the prehospital phase (i.e. assessment by EMS personnel).

Study design: multiregional, multicenter observational cohort study to investigate performance and feasibility of LAVO-prediction scales a.

Study population: all patients potentially eligible for IVTIAT according to the protocol used by EMS personnel except for when younger than 18 years.

Conditions

  • Stroke, Acute

Interventions

DIAGNOSTIC_TEST

pre hospital triage tool

EMS workers fill in an application containing 10-13 vclinical items

Sponsors & Collaborators

  • Alrijne Hospital

    collaborator OTHER

  • Medical Center Haaglanden

    collaborator OTHER

  • Haga Hospital

    collaborator OTHER

  • Groene Hart Ziekenhuis

    collaborator OTHER

  • Reinier de Graaf Groep

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-10-01
Completion
2020-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04442659 on ClinicalTrials.gov